SlideShare una empresa de Scribd logo
1 de 40
Bio 319: Antibiotics
                             Lecture Three
             Topic: Inhibitors of cell wall synthesis (brief)
                    Inhibitors of protein biosynthesis

             Lecturer: Dr. G. Kattam Maiyoh




13/02/2013                    GKM/BIO319:Antibiotics/Lec. 03/Sem02/2013   1
Inhibitors of Cell Wall Synthesis




13/02/2013     GKM/BIO319:Antibiotics/Lec. 03/Sem02/2013   2
Carbapenems
                                           • Beta-lactam ring is
                                             fused to a 5 member
                                             ring system
                                           • Effect on microbes
                                             and pharmacology
                                             of carbapenems
                                             similar to penicillins




13/02/2013      GKM/BIO319:Antibiotics/Lec. 03/Sem02/2013       3
Selected Carbapenems
• Imipenem
   – Broad spectrum including anaerobes
     and Pseudomonas aeruginosa
   – Parentally administered
   – Must be combined with cilastatin to be
     absorbed
   – Excreted by kidneys
• Meropenem, ertapenem, and doripenem
  are similar to imipenem but don’t need co-
  administration with cilastatin

cilastatin chemical compound which inhibits the human enzyme dehydropeptidase
13/02/2013              GKM/BIO319:Antibiotics/Lec. 03/Sem02/2013               4
Toxicity/Contraindications
                  of Carbapenems
• Nausea and vomiting (common)
• Hypersensitivity reactions (uncommon)
      – Essentially the same as for penicillins, exception
        is the monobactam
      – Cross-reactivity is possible, exception is the
        monobactam




                        GKM/BIO319:Antibiotics/Lec.
13/02/2013                                                   5
                             03/Sem02/2013
Aztrenam – a monobactam
• Works only on Gm -ve, including Pseudomonas
  aeruginosa
• Useful for treating G-ve infections that require
  a beta-lactam because it does not elicit
  hypersensitivity reactions

• Monobactam - beta-lactam compounds
  wherein the beta-lactam ring is alone and not
  fused to another ring
13/02/2013          GKM/BIO319:Antibiotics/Lec. 03/Sem02/2013   6
Beta-lactamase inhibitors
        a. Clavulanic acid
             – Irreversible inhibitor of β-lactamase
             – Good oral absorption
             – Combined with amoxicillin or ticarcillin




        b. Sulbactam



13/02/2013                      GKM/BIO319:Antibiotics/Lec. 03/Sem02/2013   7
Peptide Antibiotics
Peptide Antibiotics are drugs with
 polypeptides structure
Sub-group of Peptide Antibiotics
   Polymyxins
   Glycopeptides
   Bacitracin
   Streptogramins

Each drug group has its own
 mechanism of action
   4 groups and 4 mechanism
13/02/2013
                 GKM/BIO319:Antibiotics/Lec.
                                               8
                             03/Sem02/2013
• Peptide antibiotics – May be
         further classified as follows;
              –Polymyxins
                 »Polymyxin B
                 »Colistin
              –Glycopeptides
                 »Vancomycin
                 »Teicoplanin
                 »Avoparcin
              –Bacitracin
                    GKM/BIO319:Antibiotics/Lec.
13/02/2013                                        9
                         03/Sem02/2013
Polymyxins
    Drug members
        Polymyxin B
        Colistin (Polymyxin E)
    Mechanism of action
        Detergent-like action
        Damage to cell membrane function
        Bind to LPS and destroy outer membrane
           of Gram-negative bacteria
        Bactericidal
        Concentration-dependent
        Non-selective on bacterial membrane
    Spectrum of activity
        Gram-negative bacteria
                        GKM/BIO319:Antibiotics/Lec.
13/02/2013                                            10
                        03/Sem02/2013
Polymyxins
• Pharmacokinetics
   – Not absorbed via GI tract
   – If injection, drug accumulated and slowly
     excreted
• Toxicities
   – Highly toxic if systemic injection
   – Nephrotoxic
   – Neurotoxic
• Clinical uses
   – Oral treatment
   – Local treatment
                  GKM/BIO319:Antibiotics/Lec.
13/02/2013                                       11
                       03/Sem02/2013
Glycopeptides
       • Group members
          – Vancomycin
       • Antibacterial activity
          – Inhibition of cell wall synthesis
          – Active against Gram-positive bacteria
       • Not absorbed orally, must administered IV
       • High toxicity
          – Local irritation , ototoxicity, nephrotoxicity
       • Clinical uses
          – Hardly used in animals
          – Used only resistant case i.e. to beta-lactams

                         GKM/BIO319:Antibiotics/Lec.
13/02/2013                                                   12
                              03/Sem02/2013
Bacitracin
• Only member is Bacitracin
• Drug activity
  – Inhibit cell wall synthesis
  – Activity on Gram-positive bacteria
  – Bactericidal
• Nephrotoxic if systemic injection
• Clinical uses – the same as polymyxin
  – Oral – as growth promoter
  – Local or topical drugs

                  GKM/BIO319:Antibiotics/Lec.
13/02/2013                                      13
                       03/Sem02/2013
Antibiotics that Inhibit Protein Synthesis




                  GKM/BIO319:Antibiotics/Lec.
13/02/2013                                      14
                       03/Sem02/2013
Protein synthesis inhibitors
      – Aminoglycosides
      – Tetracyclins
      _Spectinomycin
      – Macrolides
      – Chloramphenicol
      – Clindamycin




                      GKM/BIO319:Antibiotics/Lec.
13/02/2013                                          15
                           03/Sem02/2013
Inhibition of Protein Synthesis by Antibiotics




                        GKM/BIO319:Antibiotics/Lec.
13/02/2013                                                    16
                             03/Sem02/2013            Figure 20.4
Review of Initiation of Protein Synthesis
                                                                    1 3
       30S                                                          2 GTP

                        1    2    3 GTP
                   Initiation Factors
                                                                                f-met-tRNA
                                                  mRNA
                                                                                Spectinomycin

                                                                            3

                      GDP + Pi
                                            50S
                             2
        P A
                                 1                                 1
                                                                   2 GTP


          70S               Aminoglycosides
                                                                      30S
      Initiation                                                   Initiation
                                     GKM/BIO319:Antibiotics/Lec.
      Complex
13/02/2013
                                          03/Sem02/2013            Complex                   17
Review of Elongation of Protein Synthesis

    P A                                               Tetracycline      P A




                                 Tu GTP               Tu GDP + Pi

                                     GTP                      Ts
                            Ts                 Tu
                                               Ts       GDP
                                                                              Chloramphenicol

                                           GDP
             Fusidic Acid                   +
                                                        GTP
                                               G


                        G GDP       +     Pi
                                                       G GTP
    P A                                                                 P A



                                                       Erythromycin
                                          GKM/BIO319:Antibiotics/Lec.
13/02/2013                                                                                18
                                               03/Sem02/2013
Survey of Antibiotics




                   GKM/BIO319:Antibiotics/Lec.
13/02/2013                                       19
                        03/Sem02/2013
Protein Synthesis Inhibitors
• Mostly bacteriostatic
• Selectivity due to differences in prokaryotic
  and eukaryotic ribosomes
• Some toxicity - eukaryotic 70S ribosomes




13/02/2013            GKM/BIO319:Antibiotics/Lec. 03/Sem02/2013   20
Antimicrobials that Bind to the 30S
                    Ribosomal Subunit




                         GKM/BIO319:Antibiotics/Lec.
13/02/2013                                             21
                              03/Sem02/2013
a) Aminoglycosides (bactericidal)
    streptomycin, kanamycin, gentamicin, tobramycin, amikacin,
    netilmicin, neomycin (topical)
• Mode of action - The aminoglycosides irreversibly bind
  to the 16S ribosomal RNA and freeze the 30S initiation
  complex (30S-mRNA-tRNA) so that no further initiation
  can occur.
• They also slow down protein synthesis that has already
  initiated and induce misreading of the mRNA.
     – By binding to the 16 S r-RNA the aminoglycosides increase
       the affinity of the A site for t-RNA regardless of the anticodon
       specificity.
• May also destabilize bacterial membranes.
                            GKM/BIO319:Antibiotics/Lec.
 13/02/2013                                                         22
                                 03/Sem02/2013
Microbe Library
             American Society for Microbiology
                 www.microbelibrary.org
                GKM/BIO319:Antibiotics/Lec.
13/02/2013                                       23
                     03/Sem02/2013
b) Aminoglycosides (bactericidal)
   streptomycin, kanamycin, gentamicin, tobramycin, amikacin,
   netilmicin, neomycin (topical)

    • Spectrum of Activity –Effective against many gram-
      negative and some gram-positive bacteria;
    • Not useful for anaerobic (oxygen required for uptake of
      antibiotic) or intracellular bacteria.
    • Resistance - Common
    • Synergy - The aminoglycosides synergize with β -lactam
      antibiotics. The β -lactams inhibit cell wall synthesis and
      thereby increase the permeability of the aminoglycosides.



13/02/2013                 GKM/BIO319:Antibiotics/Lec. 03/Sem02/2013   24
c) Tetracyclines (bacteriostatic)
tetracycline, minocycline and doxycycline

  •   Mode of action - The tetracyclines reversibly bind to the 30S
      ribosome and inhibit binding of aminoacyl-t-RNA to the acceptor site
      on the 70S ribosome.

  •   Spectrum of activity - Broad spectrum; Useful against intracellular
      bacteria

  •   Resistance - Common

  •   Adverse effects - Destruction of normal intestinal flora resulting in
      increased secondary infections; staining and impairment of the
      structure of bone and teeth.

                                GKM/BIO319:Antibiotics/Lec.
13/02/2013                                                                    25
                                     03/Sem02/2013
d) Spectinomycin (bacteriostatic)
•   Mode of action - Spectinomycin reversibly interferes with m-RNA
    interaction with the 30S ribosome. It is structurally similar to the
    aminoglycosides but does not cause misreading of mRNA.

•   Spectrum of activity - Used in the treatment of penicillin-resistant
    Neisseria gonorrhoeae

•   Resistance - Rare in Neisseria gonorrhoeae




                               GKM/BIO319:Antibiotics/Lec.
13/02/2013                                                                 26
                                    03/Sem02/2013
Antimicrobials that Bind to the 50S
                    Ribosomal Subunit




                         GKM/BIO319:Antibiotics/Lec.
13/02/2013                                             27
                              03/Sem02/2013
a) Chloramphenicol, Lincomycin,
Clindamycin (bacteriostatic)
•   Mode of action - These antimicrobials bind to the 50S ribosome and
    inhibit peptidyl transferase activity.

•   Spectrum of activity - Chloramphenicol - Broad range;
                            Lincomycin and clindamycin - Restricted range

•   Resistance - Common

•   Adverse effects - Chloramphenicol is toxic (bone marrow suppression) but
    is used in the treatment of bacterial meningitis.




                              GKM/BIO319:Antibiotics/Lec.
13/02/2013                                                                  28
                                   03/Sem02/2013
b) Macrolides (bacteriostatic)
erythromycin, clarithromycin, azithromycin, spiramycin


   • Mode of action - The macrolides inhibit translocation.

   • Spectrum of activity - Gram-positive bacteria,
     Mycoplasma, Legionella

   • Resistance - Common




                         GKM/BIO319:Antibiotics/Lec.
13/02/2013                                                    29
                              03/Sem02/2013
Macrolides : Classification
• Macrolides are drugs with lactone ring
  structure
• Sub-groups are based on no. of ring atom
   – 12-membered ring macrolides
   – 13-membered
   – 14-membered (many drugs)
   – 15-membered
   – 16-membered (many drugs)
• Special groups
   – Azalides – name for 15-membered
   – Triamilides – name for tulathromycin
     (combination of 13- and 15-membered)
   – Ketolides – name for 14-membered with 3
     keto group
Macrolides
Drug examples
13-membered
 Tulathromycin (Triamilides)
14-membered
 Erythromycin
 Clarithromycin, Roxithromycin,
  Dirithromycin
15-membered
 Azithromycin (Azalides)
 Tulathromycin (Triamilides)
16-membered
 Spiramycin
 Tylosin
Macrolides – general
      properties
• Mechanism of
  action
  – Inhibit protein
    synthesis
  – Bind to 50S
    ribosomal unit
  – Bacteriostatic
• Spectrum of
  activity
  – Gram-positive
  – Some Gram-
    negative
Macrolides
 Pharmacokinetics
  Broad distribution in body
   tissues
  High intracellular
   concentration
Macrolides
Additional properties
  of Macrolides
• Anti-inflammatory
  effect
  – Inhibitory effect on
    neutrophils
  – inhibit
    proinflammatory
    cytokines
  – Useful for treatment
    of inflammatory
Erythromycin
• Erythromycin is a standard or basic drug of
  macrolides
• Other drug members are usually compared
  with erythromycin
• Important adverse effect - severe diarrhea
   – Especially in adult horse and ruminants
• Clinical uses
   – Second choice (alternative drug)
   – Small animals
   – Fowls
   – Some cases in ruminants
   – Not used in pigs
Tylosin and Spiramycin
 • Tylosin and Spiramycin
    – Activities are similar
      to erythromycin
    – Good activity on
      Mycoplasma
 • Clinical uses
    – Macrolides used in
      ruminants and pigs
    – Used for Mycoplasma
      infection
Advanced generation
       Macrolides
Example drugs
 Roxithromycin
 Dirithromycin
 Clarithromycin
 Azithromycin
General activity – the same as erythromycin
Better Pharmacokinetic properties
 Acid stable
 Fewer GI side effect
 Higher oral availability
 Longer serum half-lives
 Higher tissue concentrations
Ketolides
• Ketolides are 14-
  membered ring
  macrolides with 3
  keto group
• Specific drugs
   – Telithromycin
   – Cethromycin (still
     in clinical study)
• Important
  properties
   – Less resistance
   – Good activities on
Antimicrobials that Interfere with
                    Elongation Factors

              Selectivity due to differences in prokaryotic and eukaryotic
                                    elongation factors




                                  GKM/BIO319:Antibiotics/Lec.
13/02/2013                                                                   39
                                       03/Sem02/2013
Fusidic acid (bacteriostatic)
•   Mode of action - Fusidic acid binds to elongation factor G (EF-G) and
    inhibits release of EF-G from the EF-G/GDP complex.

•   Spectrum of activity - Gram-positive cocci




13/02/2013                      GKM/BIO319:Antibiotics/Lec. 03/Sem02/2013   40

Más contenido relacionado

La actualidad más candente

La actualidad más candente (20)

Beta lactams antibiotics & beta lactamase inhibitors
Beta lactams antibiotics & beta lactamase inhibitors Beta lactams antibiotics & beta lactamase inhibitors
Beta lactams antibiotics & beta lactamase inhibitors
 
Chloramphenicol
ChloramphenicolChloramphenicol
Chloramphenicol
 
Metronidazole
MetronidazoleMetronidazole
Metronidazole
 
Antiretroviral drugs
Antiretroviral drugsAntiretroviral drugs
Antiretroviral drugs
 
Penicillin
PenicillinPenicillin
Penicillin
 
Beta Lactam Antibiotics
Beta Lactam Antibiotics Beta Lactam Antibiotics
Beta Lactam Antibiotics
 
Rifampicin ppt
Rifampicin pptRifampicin ppt
Rifampicin ppt
 
Vancomycin
VancomycinVancomycin
Vancomycin
 
Gentamicin
GentamicinGentamicin
Gentamicin
 
Aminoglycosides.pptx
Aminoglycosides.pptxAminoglycosides.pptx
Aminoglycosides.pptx
 
Penicillins Pharmacology
Penicillins PharmacologyPenicillins Pharmacology
Penicillins Pharmacology
 
Aminoglycosides
AminoglycosidesAminoglycosides
Aminoglycosides
 
Quinolones
QuinolonesQuinolones
Quinolones
 
Penicillins
PenicillinsPenicillins
Penicillins
 
CEPHALOSPORINS
CEPHALOSPORINSCEPHALOSPORINS
CEPHALOSPORINS
 
Polyene and polypeptide antibiotics
Polyene and polypeptide antibioticsPolyene and polypeptide antibiotics
Polyene and polypeptide antibiotics
 
Penicillin
PenicillinPenicillin
Penicillin
 
Medicinal chemistry-beta lactam antibiotics
Medicinal chemistry-beta lactam antibioticsMedicinal chemistry-beta lactam antibiotics
Medicinal chemistry-beta lactam antibiotics
 
Immunosuppressants
Immunosuppressants Immunosuppressants
Immunosuppressants
 
Macrolide antibiotics
Macrolide antibioticsMacrolide antibiotics
Macrolide antibiotics
 

Destacado

Antibiotic principles
Antibiotic principlesAntibiotic principles
Antibiotic principlesK.J Mokori
 
Presentation on antibiotics.
Presentation on antibiotics.Presentation on antibiotics.
Presentation on antibiotics.phmosarrof
 
Amol&suraj ppt penicillin
Amol&suraj ppt penicillinAmol&suraj ppt penicillin
Amol&suraj ppt penicillinAmol Pawar
 
Exploration of a potential FtsZ inhibitors as new scaffolds by Ligand and Str...
Exploration of a potential FtsZ inhibitors as new scaffolds by Ligand and Str...Exploration of a potential FtsZ inhibitors as new scaffolds by Ligand and Str...
Exploration of a potential FtsZ inhibitors as new scaffolds by Ligand and Str...Pavan Kumar
 
Pharmacology - Cell wall inhibitors 2
Pharmacology  - Cell wall inhibitors 2Pharmacology  - Cell wall inhibitors 2
Pharmacology - Cell wall inhibitors 2Areej Abu Hanieh
 
Pharmacology - Cell wall inhibitors 1
Pharmacology - Cell wall inhibitors 1Pharmacology - Cell wall inhibitors 1
Pharmacology - Cell wall inhibitors 1Areej Abu Hanieh
 
Costipation..ppt4
Costipation..ppt4Costipation..ppt4
Costipation..ppt4Amol Pawar
 
Chapter 6 inhibitors of cell wall synthesis
Chapter 6   inhibitors of cell wall synthesisChapter 6   inhibitors of cell wall synthesis
Chapter 6 inhibitors of cell wall synthesisAlia Najiha
 
Inhibitors of Cell wall and protein synthesis in bacteria BDS Sem III 20-2-15
Inhibitors of Cell wall and protein synthesis in bacteria BDS Sem III 20-2-15Inhibitors of Cell wall and protein synthesis in bacteria BDS Sem III 20-2-15
Inhibitors of Cell wall and protein synthesis in bacteria BDS Sem III 20-2-15Yahya Noori, Ph.D
 
Antibiotic Mechanisms of Action
Antibiotic Mechanisms of ActionAntibiotic Mechanisms of Action
Antibiotic Mechanisms of ActionYazan Kherallah
 
Cell wall synthesis inhibitors
Cell wall synthesis inhibitorsCell wall synthesis inhibitors
Cell wall synthesis inhibitorsDr.Reshmi Sameeth
 
Antibiotics & mechanisms of actions
Antibiotics & mechanisms of actionsAntibiotics & mechanisms of actions
Antibiotics & mechanisms of actionsabiola adeosun
 

Destacado (20)

Antibiotic principles
Antibiotic principlesAntibiotic principles
Antibiotic principles
 
Antibiotics ppt
Antibiotics pptAntibiotics ppt
Antibiotics ppt
 
Presentation on antibiotics.
Presentation on antibiotics.Presentation on antibiotics.
Presentation on antibiotics.
 
Amol&suraj ppt penicillin
Amol&suraj ppt penicillinAmol&suraj ppt penicillin
Amol&suraj ppt penicillin
 
Exploration of a potential FtsZ inhibitors as new scaffolds by Ligand and Str...
Exploration of a potential FtsZ inhibitors as new scaffolds by Ligand and Str...Exploration of a potential FtsZ inhibitors as new scaffolds by Ligand and Str...
Exploration of a potential FtsZ inhibitors as new scaffolds by Ligand and Str...
 
Cell wall inhibitors
Cell wall inhibitorsCell wall inhibitors
Cell wall inhibitors
 
Pharmacology - Cell wall inhibitors 2
Pharmacology  - Cell wall inhibitors 2Pharmacology  - Cell wall inhibitors 2
Pharmacology - Cell wall inhibitors 2
 
Pharmacology - Cell wall inhibitors 1
Pharmacology - Cell wall inhibitors 1Pharmacology - Cell wall inhibitors 1
Pharmacology - Cell wall inhibitors 1
 
Costipation..ppt4
Costipation..ppt4Costipation..ppt4
Costipation..ppt4
 
Beta lactams, protein sythesis inhibitors, other antibiotics 1-suman nizam.ii...
Beta lactams, protein sythesis inhibitors, other antibiotics 1-suman nizam.ii...Beta lactams, protein sythesis inhibitors, other antibiotics 1-suman nizam.ii...
Beta lactams, protein sythesis inhibitors, other antibiotics 1-suman nizam.ii...
 
Chapter 6 inhibitors of cell wall synthesis
Chapter 6   inhibitors of cell wall synthesisChapter 6   inhibitors of cell wall synthesis
Chapter 6 inhibitors of cell wall synthesis
 
2.ANTIBIOTIC (CELL WALL INHIBITORS)
2.ANTIBIOTIC (CELL WALL INHIBITORS)2.ANTIBIOTIC (CELL WALL INHIBITORS)
2.ANTIBIOTIC (CELL WALL INHIBITORS)
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
Penicillins (VK)
Penicillins (VK)Penicillins (VK)
Penicillins (VK)
 
Inhibitors of Cell wall and protein synthesis in bacteria BDS Sem III 20-2-15
Inhibitors of Cell wall and protein synthesis in bacteria BDS Sem III 20-2-15Inhibitors of Cell wall and protein synthesis in bacteria BDS Sem III 20-2-15
Inhibitors of Cell wall and protein synthesis in bacteria BDS Sem III 20-2-15
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
Antibiotic Mechanisms of Action
Antibiotic Mechanisms of ActionAntibiotic Mechanisms of Action
Antibiotic Mechanisms of Action
 
Spss
SpssSpss
Spss
 
Cell wall synthesis inhibitors
Cell wall synthesis inhibitorsCell wall synthesis inhibitors
Cell wall synthesis inhibitors
 
Antibiotics & mechanisms of actions
Antibiotics & mechanisms of actionsAntibiotics & mechanisms of actions
Antibiotics & mechanisms of actions
 

Similar a Antibiotics Lecture 03

inhibitor of bacterial Protein synthesis.ppt
inhibitor of bacterial Protein synthesis.pptinhibitor of bacterial Protein synthesis.ppt
inhibitor of bacterial Protein synthesis.pptDr Ndayisaba Corneille
 
Antibiotic Groups - Aminoglycosides
Antibiotic Groups - AminoglycosidesAntibiotic Groups - Aminoglycosides
Antibiotic Groups - AminoglycosidesOssama Motawae
 
AST testing.pptx
AST testing.pptxAST testing.pptx
AST testing.pptxsknjoroge
 
Antibiotics inhibiting protein synthesis 2 aminoglycosides 03 05-2018
Antibiotics inhibiting protein synthesis 2 aminoglycosides 03 05-2018Antibiotics inhibiting protein synthesis 2 aminoglycosides 03 05-2018
Antibiotics inhibiting protein synthesis 2 aminoglycosides 03 05-2018Ravi Kant Agrawal
 
antibioticsmechanismsofactions-150428084652-conversion-gate02.pdf
antibioticsmechanismsofactions-150428084652-conversion-gate02.pdfantibioticsmechanismsofactions-150428084652-conversion-gate02.pdf
antibioticsmechanismsofactions-150428084652-conversion-gate02.pdfBucky10
 
Aminoglycoside and spectinomycin
Aminoglycoside and spectinomycinAminoglycoside and spectinomycin
Aminoglycoside and spectinomycinYjnuuuhhh
 
SUMMARIZATION OF ANTIBIOTICS.pptx
SUMMARIZATION OF ANTIBIOTICS.pptxSUMMARIZATION OF ANTIBIOTICS.pptx
SUMMARIZATION OF ANTIBIOTICS.pptxdhanushyagopal
 
biosynthesis of the cell wall and antibiotics
biosynthesis of the cell wall and antibioticsbiosynthesis of the cell wall and antibiotics
biosynthesis of the cell wall and antibioticsSafaFallah
 
Aminoglycoside and Tetracyclines Antibiotics
Aminoglycoside and Tetracyclines AntibioticsAminoglycoside and Tetracyclines Antibiotics
Aminoglycoside and Tetracyclines AntibioticsProf. Aejaz Ahmed Boraji
 

Similar a Antibiotics Lecture 03 (20)

Lecture 02
Lecture 02Lecture 02
Lecture 02
 
Antibiotics Lecture 04
Antibiotics Lecture 04Antibiotics Lecture 04
Antibiotics Lecture 04
 
inhibitor of bacterial Protein synthesis.ppt
inhibitor of bacterial Protein synthesis.pptinhibitor of bacterial Protein synthesis.ppt
inhibitor of bacterial Protein synthesis.ppt
 
Antibiotic Groups - Aminoglycosides
Antibiotic Groups - AminoglycosidesAntibiotic Groups - Aminoglycosides
Antibiotic Groups - Aminoglycosides
 
Aminoglycosides
AminoglycosidesAminoglycosides
Aminoglycosides
 
Aminoglycosides
AminoglycosidesAminoglycosides
Aminoglycosides
 
Antibiotics2008
Antibiotics2008Antibiotics2008
Antibiotics2008
 
AST testing.pptx
AST testing.pptxAST testing.pptx
AST testing.pptx
 
Antibiotics inhibiting protein synthesis 2 aminoglycosides 03 05-2018
Antibiotics inhibiting protein synthesis 2 aminoglycosides 03 05-2018Antibiotics inhibiting protein synthesis 2 aminoglycosides 03 05-2018
Antibiotics inhibiting protein synthesis 2 aminoglycosides 03 05-2018
 
antibioticsmechanismsofactions-150428084652-conversion-gate02.pdf
antibioticsmechanismsofactions-150428084652-conversion-gate02.pdfantibioticsmechanismsofactions-150428084652-conversion-gate02.pdf
antibioticsmechanismsofactions-150428084652-conversion-gate02.pdf
 
Aminoglycoside and spectinomycin
Aminoglycoside and spectinomycinAminoglycoside and spectinomycin
Aminoglycoside and spectinomycin
 
Biochemistry quiz 3
Biochemistry quiz 3Biochemistry quiz 3
Biochemistry quiz 3
 
SUMMARIZATION OF ANTIBIOTICS.pptx
SUMMARIZATION OF ANTIBIOTICS.pptxSUMMARIZATION OF ANTIBIOTICS.pptx
SUMMARIZATION OF ANTIBIOTICS.pptx
 
Aminoglycoside antibiotics
Aminoglycoside antibioticsAminoglycoside antibiotics
Aminoglycoside antibiotics
 
biosynthesis of the cell wall and antibiotics
biosynthesis of the cell wall and antibioticsbiosynthesis of the cell wall and antibiotics
biosynthesis of the cell wall and antibiotics
 
chemo.pptx
chemo.pptxchemo.pptx
chemo.pptx
 
Aminoglycoside and Tetracyclines Antibiotics
Aminoglycoside and Tetracyclines AntibioticsAminoglycoside and Tetracyclines Antibiotics
Aminoglycoside and Tetracyclines Antibiotics
 
Classes of antimicrobial agents
Classes of antimicrobial agentsClasses of antimicrobial agents
Classes of antimicrobial agents
 
Glutathione - Quicksilver Scientific
Glutathione - Quicksilver ScientificGlutathione - Quicksilver Scientific
Glutathione - Quicksilver Scientific
 
Aminoglycosides and their uses.
Aminoglycosides and their uses.Aminoglycosides and their uses.
Aminoglycosides and their uses.
 

Más de Dr. Geoffrey K. K. Maiyoh

Msb 206. amino acid catab and fates of cs.2014
Msb 206. amino acid catab and fates of cs.2014Msb 206. amino acid catab and fates of cs.2014
Msb 206. amino acid catab and fates of cs.2014Dr. Geoffrey K. K. Maiyoh
 
Cellular respiration (glycolysis, TCA and ETC)
Cellular respiration (glycolysis, TCA and ETC)Cellular respiration (glycolysis, TCA and ETC)
Cellular respiration (glycolysis, TCA and ETC)Dr. Geoffrey K. K. Maiyoh
 
Chemistry of Carbohydrates and Nucleic acids - An introduction
Chemistry of Carbohydrates and Nucleic acids - An introductionChemistry of Carbohydrates and Nucleic acids - An introduction
Chemistry of Carbohydrates and Nucleic acids - An introductionDr. Geoffrey K. K. Maiyoh
 

Más de Dr. Geoffrey K. K. Maiyoh (20)

Cancer in kenya
Cancer in kenyaCancer in kenya
Cancer in kenya
 
Celebrating Kenya
Celebrating KenyaCelebrating Kenya
Celebrating Kenya
 
Lecture 05.2014
Lecture 05.2014Lecture 05.2014
Lecture 05.2014
 
Lecture 04.2014
Lecture 04.2014Lecture 04.2014
Lecture 04.2014
 
Lecture 03.2014
Lecture 03.2014Lecture 03.2014
Lecture 03.2014
 
Lecture 01.2014
Lecture 01.2014Lecture 01.2014
Lecture 01.2014
 
Mineralocorticoids & glucocorticoids
Mineralocorticoids & glucocorticoidsMineralocorticoids & glucocorticoids
Mineralocorticoids & glucocorticoids
 
Molecular diagnostics
Molecular diagnosticsMolecular diagnostics
Molecular diagnostics
 
obesity diabetes and metabolic syndrome
obesity diabetes and metabolic syndromeobesity diabetes and metabolic syndrome
obesity diabetes and metabolic syndrome
 
Dsb 106. intergration of metabolism.2014
Dsb 106. intergration of metabolism.2014Dsb 106. intergration of metabolism.2014
Dsb 106. intergration of metabolism.2014
 
Bpt 114. purine and pyrimidine metabolism
Bpt 114. purine and pyrimidine metabolismBpt 114. purine and pyrimidine metabolism
Bpt 114. purine and pyrimidine metabolism
 
Msp 304. gsd,gout,a cuduria and lesh.2014
Msp 304. gsd,gout,a cuduria and lesh.2014Msp 304. gsd,gout,a cuduria and lesh.2014
Msp 304. gsd,gout,a cuduria and lesh.2014
 
Msb 206. amino acid catab and fates of cs.2014
Msb 206. amino acid catab and fates of cs.2014Msb 206. amino acid catab and fates of cs.2014
Msb 206. amino acid catab and fates of cs.2014
 
Cellular respiration (glycolysis, TCA and ETC)
Cellular respiration (glycolysis, TCA and ETC)Cellular respiration (glycolysis, TCA and ETC)
Cellular respiration (glycolysis, TCA and ETC)
 
Chemistry of Carbohydrates and Nucleic acids - An introduction
Chemistry of Carbohydrates and Nucleic acids - An introductionChemistry of Carbohydrates and Nucleic acids - An introduction
Chemistry of Carbohydrates and Nucleic acids - An introduction
 
ANTIBIOTICS Lecture 06
ANTIBIOTICS Lecture 06ANTIBIOTICS Lecture 06
ANTIBIOTICS Lecture 06
 
ANTIBIOTICS Lecture 05
ANTIBIOTICS Lecture 05ANTIBIOTICS Lecture 05
ANTIBIOTICS Lecture 05
 
Antibiotics Lecture 01
Antibiotics Lecture 01Antibiotics Lecture 01
Antibiotics Lecture 01
 
Gout,a cuduria les
Gout,a cuduria lesGout,a cuduria les
Gout,a cuduria les
 
Msb 203...cardio res sys.tg.pl.sl
Msb 203...cardio res sys.tg.pl.slMsb 203...cardio res sys.tg.pl.sl
Msb 203...cardio res sys.tg.pl.sl
 

Antibiotics Lecture 03

  • 1. Bio 319: Antibiotics Lecture Three Topic: Inhibitors of cell wall synthesis (brief) Inhibitors of protein biosynthesis Lecturer: Dr. G. Kattam Maiyoh 13/02/2013 GKM/BIO319:Antibiotics/Lec. 03/Sem02/2013 1
  • 2. Inhibitors of Cell Wall Synthesis 13/02/2013 GKM/BIO319:Antibiotics/Lec. 03/Sem02/2013 2
  • 3. Carbapenems • Beta-lactam ring is fused to a 5 member ring system • Effect on microbes and pharmacology of carbapenems similar to penicillins 13/02/2013 GKM/BIO319:Antibiotics/Lec. 03/Sem02/2013 3
  • 4. Selected Carbapenems • Imipenem – Broad spectrum including anaerobes and Pseudomonas aeruginosa – Parentally administered – Must be combined with cilastatin to be absorbed – Excreted by kidneys • Meropenem, ertapenem, and doripenem are similar to imipenem but don’t need co- administration with cilastatin cilastatin chemical compound which inhibits the human enzyme dehydropeptidase 13/02/2013 GKM/BIO319:Antibiotics/Lec. 03/Sem02/2013 4
  • 5. Toxicity/Contraindications of Carbapenems • Nausea and vomiting (common) • Hypersensitivity reactions (uncommon) – Essentially the same as for penicillins, exception is the monobactam – Cross-reactivity is possible, exception is the monobactam GKM/BIO319:Antibiotics/Lec. 13/02/2013 5 03/Sem02/2013
  • 6. Aztrenam – a monobactam • Works only on Gm -ve, including Pseudomonas aeruginosa • Useful for treating G-ve infections that require a beta-lactam because it does not elicit hypersensitivity reactions • Monobactam - beta-lactam compounds wherein the beta-lactam ring is alone and not fused to another ring 13/02/2013 GKM/BIO319:Antibiotics/Lec. 03/Sem02/2013 6
  • 7. Beta-lactamase inhibitors a. Clavulanic acid – Irreversible inhibitor of β-lactamase – Good oral absorption – Combined with amoxicillin or ticarcillin b. Sulbactam 13/02/2013 GKM/BIO319:Antibiotics/Lec. 03/Sem02/2013 7
  • 8. Peptide Antibiotics Peptide Antibiotics are drugs with polypeptides structure Sub-group of Peptide Antibiotics Polymyxins Glycopeptides Bacitracin Streptogramins Each drug group has its own mechanism of action 4 groups and 4 mechanism 13/02/2013 GKM/BIO319:Antibiotics/Lec. 8 03/Sem02/2013
  • 9. • Peptide antibiotics – May be further classified as follows; –Polymyxins »Polymyxin B »Colistin –Glycopeptides »Vancomycin »Teicoplanin »Avoparcin –Bacitracin GKM/BIO319:Antibiotics/Lec. 13/02/2013 9 03/Sem02/2013
  • 10. Polymyxins Drug members Polymyxin B Colistin (Polymyxin E) Mechanism of action Detergent-like action Damage to cell membrane function Bind to LPS and destroy outer membrane of Gram-negative bacteria Bactericidal Concentration-dependent Non-selective on bacterial membrane Spectrum of activity Gram-negative bacteria GKM/BIO319:Antibiotics/Lec. 13/02/2013 10 03/Sem02/2013
  • 11. Polymyxins • Pharmacokinetics – Not absorbed via GI tract – If injection, drug accumulated and slowly excreted • Toxicities – Highly toxic if systemic injection – Nephrotoxic – Neurotoxic • Clinical uses – Oral treatment – Local treatment GKM/BIO319:Antibiotics/Lec. 13/02/2013 11 03/Sem02/2013
  • 12. Glycopeptides • Group members – Vancomycin • Antibacterial activity – Inhibition of cell wall synthesis – Active against Gram-positive bacteria • Not absorbed orally, must administered IV • High toxicity – Local irritation , ototoxicity, nephrotoxicity • Clinical uses – Hardly used in animals – Used only resistant case i.e. to beta-lactams GKM/BIO319:Antibiotics/Lec. 13/02/2013 12 03/Sem02/2013
  • 13. Bacitracin • Only member is Bacitracin • Drug activity – Inhibit cell wall synthesis – Activity on Gram-positive bacteria – Bactericidal • Nephrotoxic if systemic injection • Clinical uses – the same as polymyxin – Oral – as growth promoter – Local or topical drugs GKM/BIO319:Antibiotics/Lec. 13/02/2013 13 03/Sem02/2013
  • 14. Antibiotics that Inhibit Protein Synthesis GKM/BIO319:Antibiotics/Lec. 13/02/2013 14 03/Sem02/2013
  • 15. Protein synthesis inhibitors – Aminoglycosides – Tetracyclins _Spectinomycin – Macrolides – Chloramphenicol – Clindamycin GKM/BIO319:Antibiotics/Lec. 13/02/2013 15 03/Sem02/2013
  • 16. Inhibition of Protein Synthesis by Antibiotics GKM/BIO319:Antibiotics/Lec. 13/02/2013 16 03/Sem02/2013 Figure 20.4
  • 17. Review of Initiation of Protein Synthesis 1 3 30S 2 GTP 1 2 3 GTP Initiation Factors f-met-tRNA mRNA Spectinomycin 3 GDP + Pi 50S 2 P A 1 1 2 GTP 70S Aminoglycosides 30S Initiation Initiation GKM/BIO319:Antibiotics/Lec. Complex 13/02/2013 03/Sem02/2013 Complex 17
  • 18. Review of Elongation of Protein Synthesis P A Tetracycline P A Tu GTP Tu GDP + Pi GTP Ts Ts Tu Ts GDP Chloramphenicol GDP Fusidic Acid + GTP G G GDP + Pi G GTP P A P A Erythromycin GKM/BIO319:Antibiotics/Lec. 13/02/2013 18 03/Sem02/2013
  • 19. Survey of Antibiotics GKM/BIO319:Antibiotics/Lec. 13/02/2013 19 03/Sem02/2013
  • 20. Protein Synthesis Inhibitors • Mostly bacteriostatic • Selectivity due to differences in prokaryotic and eukaryotic ribosomes • Some toxicity - eukaryotic 70S ribosomes 13/02/2013 GKM/BIO319:Antibiotics/Lec. 03/Sem02/2013 20
  • 21. Antimicrobials that Bind to the 30S Ribosomal Subunit GKM/BIO319:Antibiotics/Lec. 13/02/2013 21 03/Sem02/2013
  • 22. a) Aminoglycosides (bactericidal) streptomycin, kanamycin, gentamicin, tobramycin, amikacin, netilmicin, neomycin (topical) • Mode of action - The aminoglycosides irreversibly bind to the 16S ribosomal RNA and freeze the 30S initiation complex (30S-mRNA-tRNA) so that no further initiation can occur. • They also slow down protein synthesis that has already initiated and induce misreading of the mRNA. – By binding to the 16 S r-RNA the aminoglycosides increase the affinity of the A site for t-RNA regardless of the anticodon specificity. • May also destabilize bacterial membranes. GKM/BIO319:Antibiotics/Lec. 13/02/2013 22 03/Sem02/2013
  • 23. Microbe Library American Society for Microbiology www.microbelibrary.org GKM/BIO319:Antibiotics/Lec. 13/02/2013 23 03/Sem02/2013
  • 24. b) Aminoglycosides (bactericidal) streptomycin, kanamycin, gentamicin, tobramycin, amikacin, netilmicin, neomycin (topical) • Spectrum of Activity –Effective against many gram- negative and some gram-positive bacteria; • Not useful for anaerobic (oxygen required for uptake of antibiotic) or intracellular bacteria. • Resistance - Common • Synergy - The aminoglycosides synergize with β -lactam antibiotics. The β -lactams inhibit cell wall synthesis and thereby increase the permeability of the aminoglycosides. 13/02/2013 GKM/BIO319:Antibiotics/Lec. 03/Sem02/2013 24
  • 25. c) Tetracyclines (bacteriostatic) tetracycline, minocycline and doxycycline • Mode of action - The tetracyclines reversibly bind to the 30S ribosome and inhibit binding of aminoacyl-t-RNA to the acceptor site on the 70S ribosome. • Spectrum of activity - Broad spectrum; Useful against intracellular bacteria • Resistance - Common • Adverse effects - Destruction of normal intestinal flora resulting in increased secondary infections; staining and impairment of the structure of bone and teeth. GKM/BIO319:Antibiotics/Lec. 13/02/2013 25 03/Sem02/2013
  • 26. d) Spectinomycin (bacteriostatic) • Mode of action - Spectinomycin reversibly interferes with m-RNA interaction with the 30S ribosome. It is structurally similar to the aminoglycosides but does not cause misreading of mRNA. • Spectrum of activity - Used in the treatment of penicillin-resistant Neisseria gonorrhoeae • Resistance - Rare in Neisseria gonorrhoeae GKM/BIO319:Antibiotics/Lec. 13/02/2013 26 03/Sem02/2013
  • 27. Antimicrobials that Bind to the 50S Ribosomal Subunit GKM/BIO319:Antibiotics/Lec. 13/02/2013 27 03/Sem02/2013
  • 28. a) Chloramphenicol, Lincomycin, Clindamycin (bacteriostatic) • Mode of action - These antimicrobials bind to the 50S ribosome and inhibit peptidyl transferase activity. • Spectrum of activity - Chloramphenicol - Broad range; Lincomycin and clindamycin - Restricted range • Resistance - Common • Adverse effects - Chloramphenicol is toxic (bone marrow suppression) but is used in the treatment of bacterial meningitis. GKM/BIO319:Antibiotics/Lec. 13/02/2013 28 03/Sem02/2013
  • 29. b) Macrolides (bacteriostatic) erythromycin, clarithromycin, azithromycin, spiramycin • Mode of action - The macrolides inhibit translocation. • Spectrum of activity - Gram-positive bacteria, Mycoplasma, Legionella • Resistance - Common GKM/BIO319:Antibiotics/Lec. 13/02/2013 29 03/Sem02/2013
  • 30. Macrolides : Classification • Macrolides are drugs with lactone ring structure • Sub-groups are based on no. of ring atom – 12-membered ring macrolides – 13-membered – 14-membered (many drugs) – 15-membered – 16-membered (many drugs) • Special groups – Azalides – name for 15-membered – Triamilides – name for tulathromycin (combination of 13- and 15-membered) – Ketolides – name for 14-membered with 3 keto group
  • 31. Macrolides Drug examples 13-membered Tulathromycin (Triamilides) 14-membered Erythromycin Clarithromycin, Roxithromycin, Dirithromycin 15-membered Azithromycin (Azalides) Tulathromycin (Triamilides) 16-membered Spiramycin Tylosin
  • 32. Macrolides – general properties • Mechanism of action – Inhibit protein synthesis – Bind to 50S ribosomal unit – Bacteriostatic • Spectrum of activity – Gram-positive – Some Gram- negative
  • 33. Macrolides Pharmacokinetics Broad distribution in body tissues High intracellular concentration
  • 34. Macrolides Additional properties of Macrolides • Anti-inflammatory effect – Inhibitory effect on neutrophils – inhibit proinflammatory cytokines – Useful for treatment of inflammatory
  • 35. Erythromycin • Erythromycin is a standard or basic drug of macrolides • Other drug members are usually compared with erythromycin • Important adverse effect - severe diarrhea – Especially in adult horse and ruminants • Clinical uses – Second choice (alternative drug) – Small animals – Fowls – Some cases in ruminants – Not used in pigs
  • 36. Tylosin and Spiramycin • Tylosin and Spiramycin – Activities are similar to erythromycin – Good activity on Mycoplasma • Clinical uses – Macrolides used in ruminants and pigs – Used for Mycoplasma infection
  • 37. Advanced generation Macrolides Example drugs Roxithromycin Dirithromycin Clarithromycin Azithromycin General activity – the same as erythromycin Better Pharmacokinetic properties Acid stable Fewer GI side effect Higher oral availability Longer serum half-lives Higher tissue concentrations
  • 38. Ketolides • Ketolides are 14- membered ring macrolides with 3 keto group • Specific drugs – Telithromycin – Cethromycin (still in clinical study) • Important properties – Less resistance – Good activities on
  • 39. Antimicrobials that Interfere with Elongation Factors Selectivity due to differences in prokaryotic and eukaryotic elongation factors GKM/BIO319:Antibiotics/Lec. 13/02/2013 39 03/Sem02/2013
  • 40. Fusidic acid (bacteriostatic) • Mode of action - Fusidic acid binds to elongation factor G (EF-G) and inhibits release of EF-G from the EF-G/GDP complex. • Spectrum of activity - Gram-positive cocci 13/02/2013 GKM/BIO319:Antibiotics/Lec. 03/Sem02/2013 40